D. M. Jackman

The PhenX Toolkit: Get the Most From Your Measures

Carol M. Hamilton, Lisa C. Strader, J. G. Pratt et al. · American Journal of Epidemiology · 2011 · 870 citations · Full text

Engineering, Machine Learning, Measurement +23

Nomogram to predict the presence of<i>EGFR</i>activating mutation in lung adenocarcinoma

Nicolas Girard, Camelia S. Sima, D. M. Jackman et al. · European Respiratory Journal · 2011 · 112 citations · Full text

Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapy

Mizuki Nishino, D. M. Jackman, Pamela J. DiPiro et al. · Clinical Radiology · 2014 · 27 citations · Full text

Adaptive Radiotherapy, Radiation Therapy, Medicine +10

Long-term Survival, Clinical Activity, and Safety of Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC)

Scott Gettinger, Leora Horn, Leena Gandhi et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 23 citations · Full text

Medicine, Pharmacology, Long-term Survival +6

Phase II study of the EGFR tyrosine kinase erlotinib in patients ≥ 70 years of age with previously untreated advanced non-small cell lung carcinoma

D. M. Jackman, Joan Lucca, P. Fidias et al. · Journal of Clinical Oncology · 2005 · 17 citations

Advanced Nsclc, Median Survival, Medicine +15